CDKN2A and neoplasm: Similarly, Brca1 and Brca2 heterozygosity did not affect tumor formation induced by the Wnt-1 transgene [16], and partial deletion of the INK4a locus that encodes both p16INK4a and p19ARF did not result in increased DMBA-induced tumor formation [31].